A1ALK

N~2~-[4-(5-chloropyridin-3-yl)benzoyl]-N-{(1Z,2S)-1-imino-3-[(3R)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide

Created:	2024-04-09
Last modified:	2025-04-16

Find Related PDB Entry
1 entries where A1ALK is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	64
Chiral Atom Count	3
Bond Count	66
Aromatic Bond Count	12

2D diagram of A1ALK

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N~2~-[4-(5-chloropyridin-3-yl)benzoyl]-N-{(1Z,2S)-1-imino-3-[(3R)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide
Systematic Name (OpenEye OEToolkits)	~{N}-[(2~{S})-1-[[(2~{S})-1-azanylidene-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]-4-(5-chloranylpyridin-3-yl)benzamide
Formula	C₂₅ H₃₀ Cl N₅ O₃
Molecular Weight	483.99
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	Clc1cc(cnc1)c1ccc(cc1)C(=O)NC(CC(C)C)C(=O)NC(CC1CCNC1=O)C=N
SMILES	CACTVS	3.385	CC(C)C[CH](NC(=O)c1ccc(cc1)c2cncc(Cl)c2)C(=O)N[CH](C[CH]3CCNC3=O)C=N
SMILES	OpenEye OEToolkits	2.0.7	CC(C)CC(C(=O)NC(CC1CCNC1=O)C=N)NC(=O)c2ccc(cc2)c3cc(cnc3)Cl
Canonical SMILES	CACTVS	3.385	CC(C)C[C@H](NC(=O)c1ccc(cc1)c2cncc(Cl)c2)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C=N
Canonical SMILES	OpenEye OEToolkits	2.0.7	CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=N)NC(=O)c2ccc(cc2)c3cc(cnc3)Cl
InChI	InChI	1.06	InChI=1S/C25H30ClN5O3/c1-15(2)9-22(25(34)30-21(12-27)11-18-7-8-29-23(18)32)31-24(33)17-5-3-16(4-6-17)19-10-20(26)14-28-13-19/h3-6,10,12-15,18,21-22,27H,7-9,11H2,1-2H3,(H,29,32)(H,30,34)(H,31,33)/b27-12+/t18-,21+,22+/m1/s1
InChIKey	InChI	1.06	UXWHDTJOXYLLFG-CUEBCNBESA-N

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.